Epidemiology and successful containment of a carbapenem‐resistant Enterobacteriaceae outbreak in a Southern Italian Transplant Institute

Abstract

Introduction: Carbapenem-resistant enterobacteriaceae (CRE) infections are difficult to treat and pose a serious threat to solid organ transplant (SOT) recipients. At our institute we observed an infection burden in 2012. Methods:In order to contain the spread of CRE infections, we established a taskforce to implement guidelines suggested by the Centers for Disease Control and Prevention (CDC) for this type of outbreak. Here, we describe the epidemiology of the outbreak in our SOT population, and the effectiveness of such interventions, by comparing levels of CRE hospital-acquired infection (HAI) pre-and post-task force intervention (, respectively) through a linear regression model. Results:In this study, we included 933 patients who underwent a total of 1017 SOT procedures, 286 of whom had a CRE-positive culture (28.8%), of which 65 (22.7% of CRE positive) developed infection. One-year mortality post-SOT was significantly higher in patients with CRE infection. After the taskforce intervention, the CRE HAI rate in SOT showed a significant inverse trend (event rate: −1.28, CI −1.70 to 0.86; P < 0.01). Conclusion:In the paucity of treatment options, the application of CDC measures in our SOT institute contributed significantly to containing CRE infections. K E Y W O R D S carbapenem resistant, enterobacteriaceae, infection outbreak, infectious diseases, solid organ transplantation

Risk factors for, and molecular epidemiology and clinical outcomes of, carbapenem‐ and polymyxin‐resistant Gram‐negative bacterial infections in pregnant women, infants, and toddlers: a systematic review and meta‐analyses

“…However, the continual use of carbapenems and polymyxins to treat bacterial infections resistant to penicillins, cephalosporins, and carbapenems is increasing the rate of resistance to these last‐resort antibiotics 2,4,9,11 . The emergence of carbapenem‐resistant (CR) and/or polymyxin‐resistant (PR) MDR infections is thus limiting therapeutic options and increasing hospital stay, healthcare costs, morbidity, and mortality 12–14 . Subsequently, the WHO has classified CR Gram‐negative bacteria (CR‐GNB) as critical priority pathogens for which novel antibiotics are urgently needed 15,16 …”

Prevention and control of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae: need for a multimodal approach

“…Thus, preventing colonization/infection of ICU patients in a ward where exposure from other patients is major can be viewed as an achievement of a great importance. Even though this was not a case control study and the number of patients was limited, there is lack of information regarding risk factors, antibiotic use, and prior hospital stay in patients admitted to (6)(7)(8)(9). In contrast, data are limited for developing countries.…”

Validation and Extrapolation of a Multimodal Infection Prevention and Control Intervention on Carbapenem-Resistant Klebsiella pneumoniae in an Epidemic Region: A Historical Control Quasi-Experimental Study

“…National and global institutions have provided several recommendations for reducing CRKP incidence, including active surveillance, hand hygiene (HH), contact precautions (CP), and terminal disinfection. Various studies have been conducted to confirm the effectiveness of different IPC interventions for decreasing the CRKP incidence rate (9)(10)(11)(12)(13)(14). Our previous study also showed that comprehensive IPC interventions, including de-escalation and targeted bundles, significantly reduced the incidence of CRKP colonization/infection (4).…”